NCT05643586View on ClinicalTrials.gov

Effects of Ticagrelor Versus Prasugrel on Coronary Microcirculation in Patients Undergoing Elective Percutaneous Coronary Intervention: Results of the PROtecting MICROcirculation During Coronary Angioplasty (PROMICRO)-3 Randomised Study

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

April 14, 2019

Study Completion Date

April 14, 2019

Conditions
Coronary Artery Disease
Interventions
DRUG

Ticagrelor

Patient treated with 180 mg ticagrelor 12 hours before the procedure

DRUG

Prasugrel

Patient treated with 60 mg prasugrel 12 hours before the procedure

Trial Locations (1)

9300

Aalst cardiovascular center, Aalst

All Listed Sponsors
collaborator

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium

UNKNOWN

collaborator

Department of Advanced Biomedical Sciences, University of Naples Federico II, Italy

UNKNOWN

collaborator

CardioRISC, C-TRIC, Derry/Londonderry, Northern Ireland, UK

UNKNOWN

collaborator

University of Lausanne Hospitals

OTHER

lead

Germano Di Sciascio

OTHER

NCT05643586 - Effects of Ticagrelor Versus Prasugrel on Coronary Microcirculation in Patients Undergoing Elective Percutaneous Coronary Intervention: Results of the PROtecting MICROcirculation During Coronary Angioplasty (PROMICRO)-3 Randomised Study | Biotech Hunter | Biotech Hunter